Your browser doesn't support javascript.
loading
Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.
Wong, Edwin K S; Anderson, Holly E; Herbert, Andrew P; Challis, Rachel C; Brown, Paul; Reis, Geisilaine S; Tellez, James O; Strain, Lisa; Fluck, Nicholas; Humphrey, Ann; Macleod, Alison; Richards, Anna; Ahlert, Daniel; Santibanez-Koref, Mauro; Barlow, Paul N; Marchbank, Kevin J; Harris, Claire L; Goodship, Timothy H J; Kavanagh, David.
Afiliación
  • Wong EK; Institutes of Genetic Medicine, and.
  • Anderson HE; Institutes of Genetic Medicine, and.
  • Herbert AP; Edinburgh Biomolecular Nuclear Magnetic Resonance Unit, and.
  • Challis RC; Institutes of Genetic Medicine, and.
  • Brown P; The Renal Unit, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; and.
  • Reis GS; Institutes of Genetic Medicine, and.
  • Tellez JO; Institutes of Genetic Medicine, and.
  • Strain L; Institutes of Genetic Medicine, and.
  • Fluck N; The Renal Unit, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; and.
  • Humphrey A; The Renal Unit, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; and.
  • Macleod A; The Renal Unit, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; and.
  • Richards A; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;
  • Ahlert D; Institutes of Genetic Medicine, and.
  • Santibanez-Koref M; Institutes of Genetic Medicine, and.
  • Barlow PN; Edinburgh Biomolecular Nuclear Magnetic Resonance Unit, and.
  • Marchbank KJ; Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Harris CL; Cardiff Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Goodship TH; Institutes of Genetic Medicine, and.
  • Kavanagh D; Institutes of Genetic Medicine, and david.kavanagh@ncl.ac.uk.
J Am Soc Nephrol ; 25(11): 2425-33, 2014 Nov.
Article en En | MEDLINE | ID: mdl-24722444
ABSTRACT
Complement C3 activation is a characteristic finding in membranoproliferative GN (MPGN). This activation can be caused by immune complex deposition or an acquired or inherited defect in complement regulation. Deficiency of complement factor H has long been associated with MPGN. More recently, heterozygous genetic variants have been reported in sporadic cases of MPGN, although their functional significance has not been assessed. We describe a family with MPGN and acquired partial lipodystrophy. Although C3 nephritic factor was shown in family members with acquired partial lipodystrophy, it did not segregate with the renal phenotype. Genetic analysis revealed a novel heterozygous mutation in complement factor H (R83S) in addition to known risk polymorphisms carried by individuals with MPGN. Patients with MPGN had normal levels of factor H, and structural analysis of the mutant revealed only subtle alterations. However, functional analysis revealed profoundly reduced C3b binding, cofactor activity, and decay accelerating activity leading to loss of regulation of the alternative pathway. In summary, this family showed a confluence of common and rare functionally significant genetic risk factors causing disease. Data from our analysis of these factors highlight the role of the alternative pathway of complement in MPGN.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glomerulonefritis Membranoproliferativa / Factor H de Complemento / Vía Alternativa del Complemento / Eritrocitos / Enfermedades Renales Tipo de estudio: Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glomerulonefritis Membranoproliferativa / Factor H de Complemento / Vía Alternativa del Complemento / Eritrocitos / Enfermedades Renales Tipo de estudio: Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article